MKDCX
Price
$23.97
Change
+$0.09 (+0.38%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

MKDCX vs RNWFX

Header iconMKDCX vs RNWFX Comparison
Open Charts MKDCX vs RNWFXBanner chart's image
BlackRock Emerging Mkts K
Price$23.97
Change+$0.09 (+0.38%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
MKDCX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MKDCX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKDCX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. MKDCX (4.16B). MKDCX pays higher dividends than RNWFX: MKDCX (1.70) vs RNWFX (1.51). MKDCX was incepted earlier than RNWFX: MKDCX (7 years) vs RNWFX (23 years). MKDCX is a more actively managed with annual turnover of: 96.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than MKDCX: RNWFX (250) vs MKDCX (5000000). RNWFX annual gain was more profitable for investors over the last year : 5.86 vs. MKDCX (2.42). RNWFX return over 5 years is better than : 14.39 vs. MKDCX (0.81).
MKDCXRNWFXMKDCX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD0.6474.54914%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.16B62.2B7%
Annual Yield % from dividends1.701.51113%
Returns for 1 year2.425.8641%
Returns for 3 years-14.25-5.10279%
Returns for 5 years0.8114.396%
Returns for 10 yearsN/A42.67-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics